Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia

PHASE3RecruitingINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

March 31, 2026

Conditions
Postoperative Analgesia
Interventions
DRUG

Nalbuphine Hydrochloride Injection

PCIA,The lockout interval is set at 10 minutes, with no background infusion.

DRUG

Morphine Hydrochloride Injection

PCIA,The lockout interval is set at 10 minutes, with no background infusion.

Trial Locations (24)

Unknown

RECRUITING

Peking University First Hospital, Beijing

RECRUITING

Cangzhou People's Hospital, Cangzhou

RECRUITING

The First People's Hospital of Changde City, Changde

RECRUITING

The Third Xiangya Hospital of Central South Univerdity, Changsha

RECRUITING

Heping Hospital affiliated to Changzhi Medical College, Changzhi

RECRUITING

Chengdu Fifth People's Hospital, Chengdu

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

RECRUITING

Chongqing University Affiliated Fuling Central Hospital, Chongqing

RECRUITING

Deyang People's Hospital, Deyang

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

RECRUITING

The First Affiliated Hospital of Jinan University, Guangzhou

RECRUITING

The First Affiliated Hospital Of University Of South China, Hengyang

RECRUITING

The Second Affiliated Hospital of Jiaxing University, Jiaxing

RECRUITING

The First People's Hospital of Lianyungang, Lianyungang

RECRUITING

Liuzhou Worker's Hospital, Liuzhou

RECRUITING

Mianyang Central Hospital, Mianyang

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

The Second Nanning People's Hospital, Nanning

RECRUITING

Ningbo Medical Center LIHUILI Hospital, Ningbo

RECRUITING

Ningbo NO.2 Hospital, Ningbo

RECRUITING

Shanxi Bethune Hospital, Taiyuan

RECRUITING

The First Affiliated Hospital of Wannan Medical College, Wuhu

RECRUITING

Affiliated Hospital of Jiangnan University, Wuxi

RECRUITING

Xi'an Honghui Hospital, Xi'an

All Listed Sponsors
lead

Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd

INDUSTRY